摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-丁氧基-2-硝基苯 | 7252-51-9

中文名称
1-丁氧基-2-硝基苯
中文别名
邻硝基苯基丁基醚
英文名称
n-butyl o-nitrophenyl ether
英文别名
1-n-butoxy-2-nitrobenzene;1-butoxy-2-nitrobenzene;2-Butoxynitrobenzene;butyl-(2-nitro-phenyl)-ether;Butyl-(2-nitro-phenyl)-aether;2-Nitro-1-butyloxy-benzol
1-丁氧基-2-硝基苯化学式
CAS
7252-51-9
化学式
C10H13NO3
mdl
MFCD00024228
分子量
195.218
InChiKey
VOCILNVWSWTHNE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    118-121 °C(Press: 1 Torr)
  • 密度:
    1.116±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3
  • 重原子数:
    14
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.4
  • 拓扑面积:
    55
  • 氢给体数:
    0
  • 氢受体数:
    3

SDS

SDS:b9b8208d637fed41ce0a0007e663ab36
查看

SECTION 1: Identification of the substance/mixture and of the company/undertaking
Product identifiers
Product name : 1-BUTOXY-2-NITROBENZENE
REACH No. : A registration number is not available for this substance as the substance
or its uses are exempted from registration, the annual tonnage does not
require a registration or the registration is envisaged for a later
registration deadline.
CAS-No. : 7252-51-9
Relevant identified uses of the substance or mixture and uses advised against
Identified uses : Laboratory chemicals, Manufacture of substances



SECTION 2: Hazards identification
Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008
Acute toxicity, Oral (Category 4), H302
For the full text of the H-Statements mentioned in this Section, see Section 16.
Classification according to EU Directives 67/548/EEC or 1999/45/EC
Xn Harmful R22
For the full text of the R-phrases mentioned in this Section, see Section 16.
Label elements
Labelling according Regulation (EC) No 1272/2008
Pictogram
Signal word Warning
Hazard statement(s)
H302 Harmful if swallowed.
Precautionary statement(s) none
Supplemental Hazard none
Statements
Other hazards - none

SECTION 3: Composition/information on ingredients
Substances
Formula : C10H13NO3
Molecular Weight : 195,22 g/mol
CAS-No. : 7252-51-9
Hazardous ingredients according to Regulation (EC) No 1272/2008
Component Classification Concentration
1-BUTOXY-2-NITROBENZENE
CAS-No. 7252-51-9 Acute Tox. 4; H302 <= 100 %
Hazardous ingredients according to Directive 1999/45/EC
Component Classification Concentration
1-BUTOXY-2-NITROBENZENE
CAS-No. 7252-51-9 Xn, R22 <= 100 %
For the full text of the H-Statements and R-Phrases mentioned in this Section, see Section 16

SECTION 4: First aid measures
Description of first aid measures
General advice
Consult a physician. Show this safety data sheet to the doctor in attendance.
If inhaled
If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician.
In case of skin contact
Wash off with soap and plenty of water. Consult a physician.
In case of eye contact
Flush eyes with water as a precaution.
If swallowed
Never give anything by mouth to an unconscious person. Rinse mouth with water. Consult a physician.
Most important symptoms and effects, both acute and delayed
The most important known symptoms and effects are described in the labelling (see section 2.2) and/or in
section 11
Indication of any immediate medical attention and special treatment needed
no data available

SECTION 5: Firefighting measures
Extinguishing media
Suitable extinguishing media
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
Special hazards arising from the substance or mixture
Carbon oxides, nitrogen oxides (NOx)
Advice for firefighters
Wear self contained breathing apparatus for fire fighting if necessary.
Further information
no data available

SECTION 6: Accidental release measures
Personal precautions, protective equipment and emergency procedures
Use personal protective equipment. Avoid dust formation. Avoid breathing vapours, mist or gas. Ensure
adequate ventilation. Avoid breathing dust.
For personal protection see section 8.
Environmental precautions
Do not let product enter drains.
Methods and materials for containment and cleaning up
Pick up and arrange disposal without creating dust. Sweep up and shovel. Keep in suitable, closed
containers for disposal.
Reference to other sections
For disposal see section 13.

SECTION 7: Handling and storage
Precautions for safe handling
Avoid contact with skin and eyes. Avoid formation of dust and aerosols.
Provide appropriate exhaust ventilation at places where dust is formed.
For precautions see section 2.2.
Conditions for safe storage, including any incompatibilities
Store in cool place. Keep container tightly closed in a dry and well-ventilated place.
Specific end use(s)
Apart from the uses mentioned in section 1.2 no other specific uses are stipulated

SECTION 8: Exposure controls/personal protection
Control parameters
Components with workplace control parameters
Exposure controls
Appropriate engineering controls
Handle in accordance with good industrial hygiene and safety practice. Wash hands before breaks and
at the end of workday.
Personal protective equipment
Eye/face protection
Safety glasses with side-shields conforming to EN166 Use equipment for eye protection tested
and approved under appropriate government standards such as NIOSH (US) or EN 166(EU).
Skin protection
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique
(without touching glove's outer surface) to avoid skin contact with this product. Dispose of
contaminated gloves after use in accordance with applicable laws and good laboratory practices.
Wash and dry hands.
The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and
the standard EN 374 derived from it.
Body Protection
Complete suit protecting against chemicals, The type of protective equipment must be selected
according to the concentration and amount of the dangerous substance at the specific workplace.
Respiratory protection
For nuisance exposures use type P95 (US) or type P1 (EU EN 143) particle respirator.For higher
level protection use type OV/AG/P99 (US) or type ABEK-P2 (EU EN 143) respirator cartridges.
Use respirators and components tested and approved under appropriate government standards
such as NIOSH (US) or CEN (EU).
Control of environmental exposure
Do not let product enter drains.

SECTION 9: Physical and chemical properties
Information on basic physical and chemical properties
a) Appearance Form: solid
b) Odour no data available
c) Odour Threshold no data available
d) pH no data available
e) Melting point/freezing no data available
point
f) Initial boiling point and no data available
boiling range
g) Flash point no data available
h) Evapouration rate no data available
i) Flammability (solid, gas) no data available
j) Upper/lower no data available
flammability or
explosive limits
k) Vapour pressure no data available
l) Vapour density no data available
m) Relative density no data available
n) Water solubility no data available
o) Partition coefficient: n- log Pow: 2,568
octanol/water
p) Auto-ignition no data available
temperature
q) Decomposition no data available
temperature
r) Viscosity no data available
s) Explosive properties no data available
t) Oxidizing properties no data available
Other safety information
no data available

SECTION 10: Stability and reactivity
Reactivity
no data available
Chemical stability
Stable under recommended storage conditions.
Possibility of hazardous reactions
no data available
Conditions to avoid
no data available
Incompatible materials
Strong oxidizing agents
Hazardous decomposition products
Other decomposition products - no data available
In the event of fire: see section 5

SECTION 11: Toxicological information
Information on toxicological effects
Acute toxicity
no data available
Skin corrosion/irritation
no data available
Serious eye damage/eye irritation
no data available
Respiratory or skin sensitisation
no data available
Germ cell mutagenicity
no data available
Carcinogenicity
IARC: No component of this product present at levels greater than or equal to 0.1% is identified as
probable, possible or confirmed human carcinogen by IARC.
Reproductive toxicity
no data available
Specific target organ toxicity - single exposure
no data available
Specific target organ toxicity - repeated exposure
no data available
Aspiration hazard
no data available
Additional Information
RTECS: Not available
To the best of our knowledge, the chemical, physical, and toxicological properties have not been
thoroughly investigated.

SECTION 12: Ecological information
Toxicity
no data available
Persistence and degradability
no data available
Bioaccumulative potential
no data available
Mobility in soil
no data available
Results of PBT and vPvB assessment
PBT/vPvB assessment not available as chemical safety assessment not required/not conducted
Other adverse effects
no data available

SECTION 13: Disposal considerations
Waste treatment methods
Product
Offer surplus and non-recyclable solutions to a licensed disposal company. Dissolve or mix the material
with a combustible solvent and burn in a chemical incinerator equipped with an afterburner and scrubber.
Contaminated packaging
Dispose of as unused product.

SECTION 14: Transport information
UN number
ADR/RID: - IMDG: - IATA: -
UN proper shipping name
ADR/RID: Not dangerous goods
IMDG: Not dangerous goods
IATA: Not dangerous goods
Transport hazard class(es)
ADR/RID: - IMDG: - IATA: -
Packaging group
ADR/RID: - IMDG: - IATA: -
Environmental hazards
ADR/RID: no IMDG Marine pollutant: no IATA: no
Special precautions for user
no data available



SECTION 15 - REGULATORY INFORMATION
N/A


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    1-丁氧基-2-硝基苯 在 palladium on activated charcoal 氢气 、 sodium carbonate 作用下, 以 乙醇 为溶剂, 生成 1-(2-丁氧基苯基)哌嗪
    参考文献:
    名称:
    Activity of aromatic substituted phenylpiperazines lacking affinity for dopamine binding sites in a preclinical test of antipsychotic efficacy
    摘要:
    Generally, antipsychotic agents are dopamine receptor blocking agents that also block conditioned avoidance responding (CAR) in the rat. Recently, however, both (Q-methoxyphenyl)piperazine (OMPP, 1h) and (m-chlorophenyl)piperazine (MCPP, 1o) have been reported to block conditioned avoidance responding in the rat although neither has dopamine receptor blocking properties. The present paper examines the behavioral and biochemical profile of a number of additional substituted phenylpiperazines. None of the phenylpiperazines tested demonstrated high affinity for either dopamine D-1 or D-2 receptor sites, yet many were effective in blocking CAR. The results suggest that the phenylpiperazines may be effective antipsychotic agents without blocking dopamine receptors. Moreover, the active compounds did demonstrate activity in displacing ligand binding to serotonin receptors. Receptor binding profiles were determined for 5-HT-1A and 5-HT-1B binding sites as well as for 5-HT-2 sites. The data from this preclinical test suggest these phenylpiperazines might be effective antipsychotic agents acting via a nondopaminergic mechanism of action.
    DOI:
    10.1021/jm00125a020
  • 作为产物:
    描述:
    邻硝基苯甲酸potassium tert-butylate氧气 、 copper diacetate 、 silver carbonate 作用下, 以 乙醇N,N-二甲基甲酰胺 为溶剂, 反应 18.0h, 生成 1-丁氧基-2-硝基苯
    参考文献:
    名称:
    芳香羧酸的脱羧醚化
    摘要:
    脱羧 Chan-Evans-Lam 型偶联是一种从容易获得的芳族羧酸开始区域特异性构建二芳基和烷基芳基醚的新策略。它们允许在有氧条件下,在碳酸银作为脱羧催化剂和乙酸铜作为交叉偶联催化剂存在下,通过与原硅酸烷基酯或硼酸芳基酯反应,将各种芳族羧酸盐转化为相应的芳基醚。
    DOI:
    10.1021/ja304539j
点击查看最新优质反应信息

文献信息

  • Synthesis of Aryl Ethers from Aromatic Carboxylic Acids
    作者:Lukas Gooßen、Sukalyan Bhadra、Wojciech Dzik
    DOI:10.1055/s-0033-1339470
    日期:——
    meta-substituted carboxylates are converted into para-substituted alkoxyarenes and vice versa. The combined processes provide a convenient synthetic entry to the important class of aromatic ethers from widely available carboxylic acids. A silver/copper bimetallic catalyst system promotes the decarboxylative Chan–Evans–Lam alkoxylation of ortho-substituted aromatic carboxylate salts with tetraalkyl orthosilicates
    摘要 银/铜双金属催化剂体系可促进原位取代的芳族羧酸盐与原硅酸四烷基酯或硼酸三芳基酯的脱羧化Chan-Evans-Lam烷氧基化反应。非邻位取代的羧酸盐通过邻-C-H-烷氧基化被烷氧基化,同时羧酸酯导向基团通过原脱羧作用被裂解。这样,间位取代的羧酸盐被转化为对位取代的烷氧基芳烃,反之亦然。组合的方法可以从广泛使用的羧酸中方便地合成进入重要类别的芳族醚。 银/铜双金属催化剂体系可促进原位取代的芳族羧酸盐与原硅酸四烷基酯或硼酸三芳基酯的脱羧化Chan-Evans-Lam烷氧基化反应。非邻位取代的羧酸盐通过邻-C-H-烷氧基化被烷氧基化,同时羧酸酯导向基团通过原脱羧作用被裂解。这样,间位取代的羧酸盐被转化为对位取代的烷氧基芳烃,反之亦然。组合的方法可以从广泛使用的羧酸中方便地合成进入重要类别的芳族醚。
  • Studies on antiallergy agents. III. Synthesis of 2-anilino-1,6-dihydro-6-oxo-5-pyrimidinecarboxylic acids and related compounds.
    作者:Kohji OZEKI、Teru ICHIKAWA、Hiroyuki TAKEHARA、Kenjiro TANIMURA、Makoto SATO、Hideya YAGINUMA
    DOI:10.1248/cpb.37.1780
    日期:——
    A series of 2-anilino-1,6-dihydro-6-oxo-5-pyrimidinecarboxylic acids with various substituents was synthesized and evaluated in the rat passive cutaneous anaphylaxis test for antiallergic activity. High activity by intraperitoneal and oral administrations was observed for the 3-trifluoromethyl and 2-alkoxyanilino derivatives (64, 79, 81, 82 and 85). Structure-activity relationships are discussed.
    合成了一系列具有各种取代基的2-苯胺基-1,6-二氢-6-氧代-5-嘧啶羧酸,并在大鼠被动皮肤过敏反应试验中评估了其抗过敏活性。对于3-三氟甲基和2-烷氧基苯胺基衍生物(64、79、81、82和85),观察到腹膜内和口服给药具有高活性。讨论了构效关系。
  • Boron-Promoted Ether Interchange Reaction: Synthesis of Alkyl Nitroaromatic Ethers from Methoxynitroarenes
    作者:Zhenwei Liu、Nannan Luan、Hongtao Lu、Apeng Liang、Jingya Li、Dapeng Zou、Yangjie Wu、Yusheng Wu
    DOI:10.1002/ejoc.201901779
    日期:2020.2.14
    for boron‐promoted ether interchange reaction of methoxynitroarenes is reported. A series of methoxynitroarenes and alcohols, including primary, secondary, as well as tertiary alcohols, reacted smoothly in moderate to good yields under the optimized reaction conditions. This protocol is an operationally simple and scalable strategy for the synthesis of alkyl nitroaromatic ethers.
    报道了第一个硼促进甲氧基硝基芳烃的醚交换反应的方案。在优化的反应条件下,一系列的甲氧基硝基芳烃和醇,包括伯醇,仲醇和叔醇,以中等至良好的收率平稳反应。该协议是用于烷基硝基芳族醚合成的操作简单且可扩展的策略。
  • Nucleophilic aromatic substitution using Et3SiH/cat. t-Bu-P4 as a system for nucleophile activation
    作者:Masahiro Ueno、Misato Yonemoto、Masahiro Hashimoto、Andrew E. H. Wheatley、Hiroshi Naka、Yoshinori Kondo
    DOI:10.1039/b700140a
    日期:——
    A novel type of deprotonative arylation of nucleophiles was conducted using Et3SiH/cat. t-Bu-P4 and the powerful SNAr reactions of aryl fluorides were accomplished using alcohols and malonates as nucleophiles.
    一种新型的去质子化芳基化亲核试剂的方法被采用,使用Et3SiH/催化剂t-Bu-P4,并且通过醇和丙二酸盐作为亲核试剂,实现了强有力的芳基氟化物SNAr反应。
  • Ligand-free Cu(<scp>ii</scp>)-catalyzed aerobic etherification of aryl halides with silanes: an experimental and theoretical approach
    作者:Muhammad Naeem Ahmed、Khalil Ahmad、Khawaja Ansar Yasin、Tayyaba Farooq、Bilal Ahmad Khan、Soumendra K. Roy
    DOI:10.1039/c9nj01777a
    日期:——
    remained a focus of interest. In contrast to the conventional/traditional methods of etherification, herein, we have reported a more efficient method, which is better yielding and more general in application. The etherification of aryl halides by alkoxy/phenoxy silanes was catalyzed by copper acetate in the presence of cesium carbonate and oxygen in DMF at 145 °C. All the as-synthesized compounds were
    由于它们在自然界中的广泛应用和在各个领域的广泛应用,芳基烷基醚的合成一直是人们关注的焦点。与传统的/传统的醚化方法相比,本文报道了一种更有效的方法,该方法收率更高,应用更普遍。在碳酸铯和氧气存在下于145°C下,乙酸铜在乙酸铜的催化下,通过烷氧基/苯氧基硅烷将芳基卤化物醚化。所有所合成的化合物进行表征通过所述1 H-NMR和13C-NMR光谱技术。进行了使用B3LYP官能团的密度泛函理论计算,以阐明反应机理。2-硝基碘代苯和四甲氧基硅烷之间的C-O偶联反应被用作模型反应。用于产生催化物质(31.6 kcal mol -1)和σ键易位(16.0 kcal mol -1),氧化加成/还原消除(20.3 kcal mol -1),卤素原子转移(19.2 kcal)的活化能垒mol -1)和单电子转移(SET)(29.5 kcal mol -1)计算了C–O偶联反应的机理。使用B3PW91,PBE
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐